Jagged-1 is the key effector of EGCG-protective effect against oxLDL-induced endothelial dysfunction
EGCG attenuates the HFD-induced accumulation of atherosclerotic plaque in ApoE-deficient mice
EGCG protects ApoE-KO mice from atherosclerosis through the Jagged-1/Notch-1 pathway
Cancer
EGCG inhibits the self-renewal capacity of head and neck squamous carcinoma (HNSC) cancer stem cells (CSCs) by suppressing their sphere forming capacity and attenuates the expression of stem cell markers. EGCG augments cisplatin-mediated chemosensitivity
EGCG decreases HNSC CSC traits by inhibiting the Notch-1 pathway
BBR significantly improves cardiac function recovery and decreases myocardial apoptosis, infarct size, serum creatine kinase, and lactate dehydrogenase levels in rats following myocardial IRI
Both in vitro and in vivo, BBR upregulates NICD translocation and HES1 expression
In H9C2, BBR attenuates simulated IRI-induced myocardial apoptosis
In vitro, antiapoptotic effect of BBR is blocked by Notch-1 or HES1 siRNA
Polydatin
Cardiovascular
Following myocardial IRI, polydatin preserves cardiac function, ameliorates myocardial oxidative/nitrative stress damage, and reduces myocardial infarct size in STZ-induced diabetic rats
Polydatin exerts cardioprotection against diabetic myocardial IRI by activating myocardial Notch-1/HES1 signaling. DAPT blunts the beneficial effects of polydatin